Edition:
United States

Cancer Genetics Inc (CGIX.OQ)

CGIX.OQ on NASDAQ Stock Exchange Capital Market

0.95USD
1:44pm EDT
Change (% chg)

$-0.06 (-5.89%)
Prev Close
$1.01
Open
$1.00
Day's High
$1.00
Day's Low
$0.93
Volume
89,918
Avg. Vol
97,097
52-wk High
$4.75
52-wk Low
$0.93

Select another date:

Mon, Apr 2 2018

BRIEF-Cancer Genetics Reports Q4 Loss Per Share Of $0.35

* CANCER GENETICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND PROVIDES STRATEGIC BUSINESS UPDATES

BRIEF-Cancer Genetics Receives Non-Dilutive Funding Of $1.1 Mln

* CANCER GENETICS RECEIVES NON-DILUTIVE FUNDING OF $1.1 MILLION THROUGH NEW JERSEY TECHNOLOGY BUSINESS TAX CERTIFICATE TRANSFER (NOL) PROGRAM

BRIEF-Stonepine Capital Management Reports 5 Percent Passive Stake In Cancer Genetics

* STONEPINE CAPITAL MANAGEMENT REPORTS 5 PERCENT PASSIVE STAKE IN CANCER GENETICS INC AS ON DEC 12 - SEC FILING Source: (http://bit.ly/2p5v6Mx) Further company coverage:

BRIEF-Cancer Genetics Prices $7 Million Registered Direct Offering

* CANCER GENETICS PRICES $7 MILLION REGISTERED DIRECT OFFERING

BRIEF-Cancer Genetics Q3 loss per share $0.15

* Cancer genetics reports record third quarter 2017 revenue and 134% increase in contracted bookings from major biotech and pharmaceutical companies

Select another date: